Nippon Shinyaku (TSE:4516), Why Is It Getting Attention Today?

Nippon Shinyaku (TSE:4516) drew fresh attention after reporting first quarter 2026 earnings, with sales of ¥49,066 million and net income of ¥10,109 million, along with higher basic and diluted earnings per share.

See our latest analysis for Nippon Shinyaku.

Nippon Shinyaku’s recent earnings update appears to have lifted sentiment in the short term, with a 1-day share price return of 0.75% and 7-day share price return of 1.70%. However, the share price is still down 10.08% over 30 days and 34.22% year to date, and longer term total shareholder returns are mixed, with a 15.68% gain over 1 year but declines over 3 and 5 years.

If you want to widen your search beyond Nippon Shinyaku and see what else is moving, now could be a good time to check out 11 top founder-led companies

Nippon Shinyaku’s latest quarter points to a business that still has meaningful earnings power, yet the share price has fallen sharply this year. So is that recent weakness giving you fair value, or are you paying up for quality?

Price-to-Earnings of 7.8x: Is it justified for Nippon Shinyaku?

On a simple earnings yardstick, Nippon Shinyaku looks inexpensive. The stock closed at ¥3,640, and the current P/E of 7.8x sits well below several benchmarks that investors often watch.

The P/E ratio compares the share price to earnings per share, so it effectively tells you how much you are paying for each unit of current earnings. For a pharmaceutical company like Nippon Shinyaku, where products can have long lifecycles and research costs are substantial, this multiple is a quick way for you to see how the market values those earnings today.

Here, the company is described as good value because its P/E of 7.8x is below the estimated fair P/E of 9x. It is also below the Japan market average P/E of 14x and the JP Pharmaceuticals industry average of 15x. That is a wide gap and suggests the current market price is assigning a lower earnings multiple than both the broader market and direct peers, while the fair ratio points to a level the valuation could move toward if sentiment or expectations shift.

Explore the SWS fair ratio for Nippon Shinyaku

Result: Price-to-Earnings of 7.8x (UNDERVALUED)

However, you still need to watch the annual revenue and net income declines, along with recent multi year total return weakness, which could challenge Nippon Shinyaku’s low P/E story.

Find out about the key risks to this Nippon Shinyaku narrative.

Another view on Nippon Shinyaku using the SWS DCF model

The P/E of 7.8x makes Nippon Shinyaku look cheap on earnings. However, the SWS DCF model points in the opposite direction. At ¥3,640 the stock is trading above an estimated future cash flow value of ¥2,111.01. This frames the shares as overvalued on this approach and raises a different question for long term buyers.

For a closer look at how this cash flow view is built and what assumptions sit behind it, you can review the Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Nippon Shinyaku for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 24 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mixed signals around Nippon Shinyaku, it makes sense to look at the data yourself and decide where you stand. To weigh up both sides of the story in one place, take a close look at the 4 key rewards and 1 important warning sign

Looking for more Nippon Shinyaku investment ideas?

If Nippon Shinyaku has prompted you to reassess your portfolio, now is the moment to compare it with other opportunities using focused screens that surface different strengths.

• Spot potential value opportunities early by scanning 24 high quality undervalued stocks that combine relatively low prices with solid underlying metrics.
• Strengthen your income focus by reviewing 33 dividend fortresses that offer higher yields and may suit investors seeking regular cash returns.
• Dial down portfolio risk by checking 60 resilient stocks with low risk scores that score well on financial resilience and downside protection factors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com